Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1990 Jul;58(7):2061–2066. doi: 10.1128/iai.58.7.2061-2066.1990

Mannan composition of the hyphal form of two relatively avirulent mutants of Candida albicans.

A Saxena 1, G E McElhaney-Feser 1, R L Cihlar 1
PMCID: PMC258776  PMID: 2194957

Abstract

We have previously reported the characteristics of mannans isolated from the yeast forms of two relatively avirulent Candida albicans strains, designated 4918-2 and 4918-10. Investigations have been expanded to include an analysis of mannans from the hyphal form of these strains as well as from the hyphal form of the parental strain, 4918. After extraction, mannans were further purified by high-pressure liquid chromatography on a Bio-gel TSK DEAE-5-PW column. Subsequent to either mild acid hydrolysis, alkali hydrolysis, or acetylation followed by acetolysis, the resulting products were fractionated by high-pressure liquid chromatography on an Aminex HPX-42A column. The results of acid hydrolysis showed only minor quantitative differences in the products released from each strain, with mannose constituting the vast majority of product liberated. The profiles of mannooligosaccharides obtained from either alkali hydrolysis or acetolysis for strain 4918-2 showed distinct quantitative differences compared with profiles of the other two strains. Finally, a general characteristic noted is a decrease in the average chain length of mannooligosaccharides in hyphal mannans compared with the yeast counterpart.

Full text

PDF
2061

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calderone R. A., Cihlar R. L., Lee D. D., Hoberg K., Scheld W. M. Yeast adhesion in the pathogenesis of endocarditis due to Candida albicans: studies with adherence-negative mutants. J Infect Dis. 1985 Oct;152(4):710–715. doi: 10.1093/infdis/152.4.710. [DOI] [PubMed] [Google Scholar]
  2. Calderone R. A., Wadsworth E. Characterization of mannoproteins from a virulent Candida albicans strain and its derived, avirulent strain. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S423–S427. doi: 10.1093/cid/10.supplement_2.s423. [DOI] [PubMed] [Google Scholar]
  3. Hamada T., Nakajima T., Izaki K., Matsuda K. Comparison of the mannan structure from the cell-wall mutant Candida sp. M-7002 and its wild type. I. Characterization of the proteo-mannan from the mutant and the wild-type cells. Eur J Biochem. 1981 Oct;119(2):365–371. doi: 10.1111/j.1432-1033.1981.tb05617.x. [DOI] [PubMed] [Google Scholar]
  4. Hoberg K. A., Cihlar R. L., Calderone R. A. Characterization of cerulenin-resistant mutants of Candida albicans. Infect Immun. 1986 Jan;51(1):102–109. doi: 10.1128/iai.51.1.102-109.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Klotz S. A., Drutz D. J., Zajic J. E. Factors governing adherence of Candida species to plastic surfaces. Infect Immun. 1985 Oct;50(1):97–101. doi: 10.1128/iai.50.1.97-101.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kocourek J., Ballou C. E. Method for fingerprinting yeast cell wall mannans. J Bacteriol. 1969 Dec;100(3):1175–1181. doi: 10.1128/jb.100.3.1175-1181.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lee J. C., King R. D. Characterization of Candida albicans adherence to human vaginal epithelial cells in vitro. Infect Immun. 1983 Sep;41(3):1024–1030. doi: 10.1128/iai.41.3.1024-1030.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lehrer N., Segal E., Cihlar R. L., Calderone R. A. Pathogenesis of vaginal candidiasis: studies with a mutant which has reduced ability to adhere in vitro. J Med Vet Mycol. 1986 Apr;24(2):127–131. doi: 10.1080/02681218680000191. [DOI] [PubMed] [Google Scholar]
  9. Lloyd K. O. Isolation, characterization, and partial structure of peptido galactomannans from the yeast form of Cladosporium werneckii. Biochemistry. 1970 Aug 18;9(17):3446–3453. doi: 10.1021/bi00819a025. [DOI] [PubMed] [Google Scholar]
  10. Maisch P. A., Calderone R. A. Role of surface mannan in the adherence of Candida albicans to fibrin-platelet clots formed in vitro. Infect Immun. 1981 Apr;32(1):92–97. doi: 10.1128/iai.32.1.92-97.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Manning M., Mitchell T. G. Strain variation and morphogenesis of yeast- and mycelial-phase Candida albicans in low-sulfate, synthetic medium. J Bacteriol. 1980 May;142(2):714–719. doi: 10.1128/jb.142.2.714-719.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McCourtie J., Douglas L. J. Relationship between cell surface composition of Candida albicans and adherence to acrylic after growth on different carbon sources. Infect Immun. 1981 Jun;32(3):1234–1241. doi: 10.1128/iai.32.3.1234-1241.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McCourtie J., Douglas L. J. Relationship between cell surface composition, adherence, and virulence of Candida albicans. Infect Immun. 1984 Jul;45(1):6–12. doi: 10.1128/iai.45.1.6-12.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Omura S. Cerulenin. Methods Enzymol. 1981;72:520–532. [PubMed] [Google Scholar]
  15. Omura S. The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bacteriol Rev. 1976 Sep;40(3):681–697. doi: 10.1128/br.40.3.681-697.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Peterson G. L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977 Dec;83(2):346–356. doi: 10.1016/0003-2697(77)90043-4. [DOI] [PubMed] [Google Scholar]
  17. Samaranayake L. P., MacFarlane T. W. The adhesion of the yeast Candida albicans to epithelial cells of human origin in vitro. Arch Oral Biol. 1981;26(10):815–820. doi: 10.1016/0003-9969(81)90178-3. [DOI] [PubMed] [Google Scholar]
  18. Saxena A., Hammer C. F., Cihlar R. L. Analysis of mannans of two relatively avirulent mutant strains of Candida albicans. Infect Immun. 1989 Feb;57(2):413–419. doi: 10.1128/iai.57.2.413-419.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Shibata N., Ichikawa T., Tojo M., Takahashi M., Ito N., Okubo Y., Suzuki S. Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide. Arch Biochem Biophys. 1985 Dec;243(2):338–348. doi: 10.1016/0003-9861(85)90511-9. [DOI] [PubMed] [Google Scholar]
  20. Shibata N., Ichikawa T., Tojo M., Takahashi M., Ito N., Okubo Y., Suzuki S. Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide. Arch Biochem Biophys. 1985 Dec;243(2):338–348. doi: 10.1016/0003-9861(85)90511-9. [DOI] [PubMed] [Google Scholar]
  21. Shibata N., Kobayashi H., Tojo M., Suzuki S. Characterization of phosphomannan-protein complexes isolated from viable cells of yeast and mycelial forms of Candida albicans NIH B-792 strain by the action of Zymolyase-100T. Arch Biochem Biophys. 1986 Dec;251(2):697–708. doi: 10.1016/0003-9861(86)90379-6. [DOI] [PubMed] [Google Scholar]
  22. Suzuki M., Fukazawa Y. Immunochemical characterization of Candida albicans cell wall antigens: specific determinant of Candida albicans serotype A mannan. Microbiol Immunol. 1982;26(5):387–402. doi: 10.1111/j.1348-0421.1982.tb00189.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES